[EN] AZABICYCLE-SUBSTITUTED PHENYLINDOLE DERIVATIVES AS LIGANDS FOR 5-HT2A RECEPTORS<br/>[FR] DERIVES DE PHENYLINDOLE A SUBSTITUTION AZABICYCLIQUE EN TANT QUE LIGANDS DES RECEPTEURS 5-HT2A
申请人:MERCK SHARP & DOHME
公开号:WO2000004017A1
公开(公告)日:2000-01-27
Compounds of formula (I), or a salt thereof wherein the broken line represents an optional chemical bond; A and B independently represent hydrogen, halogen, cyano, nitro, trifluoromethyl, trifluoromethoxy; C1-6alkyl or C1-6alkoxy; or A and B, when attached to adjacent carbon atoms, together represent methylenedioxy; X and Y independently represent hydrogen, halogen, trifluoromethyl, trifluoromethoxy, C1-6alkyl, C1-6alkoxy or phenyl; Q represents a group of the formula -CH2CH2- or -CH2CH2CH2-; R1 represents hydrogen, C¿1-6?alkyl, or an optionally substituted aryl(C1-6)alkyl, heteroaryl(C1-6)alkyl or C3-7heterocycloalkyl(C1-6)alkyl group; and R?2¿ represents hydrogen, halogen. C¿1-6?alkyl, hydroxy or C1-6alkoxy are selective antagonists of the human 5-HT2A receptor and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of adverse conditions of the central nervous system, including psychotic disorders such as schizophrenia.